'Progressive diabetic nephropathy. How useful is microalbuminuria?: contra'

Area of Science:

• Nephrology
• Endocrinology
• Diabetology

Background:

• Microalbuminuria has been a cornerstone in diabetic kidney disease (DKD) research and clinical practice.
• Recent evidence questions the sole reliance on microalbuminuria for DKD paradigm.
• Microalbuminuria's predictive value for kidney outcomes in diabetes is limited due to sensitivity and specificity issues.

Purpose of the Study:

• To evaluate the current role of microalbuminuria in assessing diabetic kidney disease (DKD).
• To highlight the limitations of microalbuminuria as a sole predictor of kidney outcomes in diabetes.
• To advocate for the development of broader DKD models beyond the traditional albuminuric pathway.

Main Methods:

• Review of existing literature on microalbuminuria and diabetic kidney disease (DKD).
• Analysis of the relationship between microalbuminuria levels, rate of change, and kidney function decline (GFR).
• Examination of spontaneous remission rates of microalbuminuria and its implications.

Main Results:

• Microalbuminuria levels and changes correlate with DKD development but lack predictive accuracy alone.
• Spontaneous remission of microalbuminuria is common, challenging its status as an irreversible DKD stage.
• Absence or progression of microalbuminuria does not guarantee protection against glomerular filtration rate (GFR) decline.
• Intervention studies have not robustly confirmed the link between reduced microalbuminuria and slower GFR decline.

Conclusions:

• Overemphasis on microalbuminuria in diabetes can lead to flawed conclusions about kidney health.
• Microalbuminuria's utility as a surrogate endpoint in intervention trials is undermined.
• Broader DKD models incorporating novel risk markers are essential for accurate prediction and management.